David K. Wilson
Fellow
Also affiliated: Boston University (2008); Tufts University (2008); Brigham and Women's Hospital (2008); University of Vienna (2002); Arkansas Children's Hospital (2025); Battelle (1996); Howard Hughes Medical Institute (1988–1997); Harvard University (2008); Baylor College of Medicine (1988–1997); University of Zurich (2017–2018); University of Arkansas Medical Center (2025); Graz University of Technology (2004); Cancer Research Center (2006); Trinity University (2024–2025); Rice University (1988–1996); University of Missouri (2018); University of California, Davis (2000–2020)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
David K. Wilson is a researcher with an h-index of 35 and over 118 publications, accumulating more than 3,707 citations. He is recognized as a highly cited researcher and leads a research group at the University of Arkansas for Medical Sciences. His collaborative network includes Murat Gökden, Kevin Bielamowicz, Eylem Öcal, and Sateesh Jayappa, with whom he has co-authored multiple publications.
Wilson's recent publications span diverse areas, including medical case studies on pediatric gliomas and germinomas, and research into neonatal Langerhans cell histiocytosis. His work also extends to fundamental scientific investigations, such as studies on the nature of nickel-halogen bonds and the preparation and characterization of high-valent metal complexes. Additionally, his research addresses the health and healthcare utilization of children with sickle cell disease, including the impact of parental adverse childhood experiences and neurocognitive assessments in adolescents.
His scholarly contributions are evident in his extensive publication record and citation count, indicating a significant impact within his research fields. His recent activity in 2024 and 2025 demonstrates ongoing engagement with scientific inquiry.
Metrics
- h-index: 35
- Publications: 118
- Citations: 3,717
Selected Publications
-
An unusual exchange: neonatal jaundice revealing congenital dyserythropoietic anemia (2026)
-
Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease (2025)
-
Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance (2025)
-
TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE (2025)
-
Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease (2025)
-
A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case (2025)
-
Isolated eyelid neonatal Langerhans cell histiocytosis (2024)
Collaboration Network
Top Collaborators
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Isolated eyelid neonatal Langerhans cell histiocytosis
Similar Researchers
Based on overlapping research topics